Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded cytochrome b (MT-CYB), commonly known as Cytochrome b, is a critical, mitochondrially encoded subunit of the ubiquinol-cytochrome c reductase complex (Complex III or cytochrome b-c1 complex) located in the inner mitochondrial membrane. It plays an essential role in the mitochondrial respiratory chain by mediating electron transfer from ubiquinol to cytochrome c, which is coupled to proton translocation across the inner membrane to generate the proton-motive force required for ATP synthesis. MT-CYB contains two distinct quinone-binding pockets: the quinol oxidation site (Qo) and the quinone reduction site (Qi). As a therapeutic target, MT-CYB is highly validated for antimicrobial and antiparasitic therapies; for instance, the FDA-approved drug atovaquone targets the Qo site of MT-CYB to treat malaria, pneumocystis pneumonia, and toxoplasmosis. Additionally, MT-CYB is being explored as a target in oncology to inhibit oxidative phosphorylation in cancer stem cells, thereby suppressing tumor growth. However, targeting MT-CYB is associated with challenges, notably the rapid emergence of drug-resistance mutations in pathogens and potential host mitochondrial toxicity.
Inhibition of the ubiquinol-cytochrome c reductase complex (Complex III) by binding to the Qo (quinol oxidation) or Qi (quinone reduction) sites within the cytochrome b subunit, thereby blocking electron transfer and ATP synthesis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome b (MT-CYB).